Robert Berg

Robert Berg Email and Phone Number

CFO at Kindeva Drug Delivery @ Kindeva Drug Delivery
Robert Berg's Location
St Charles, Missouri, United States, United States
Robert Berg's Contact Details

Robert Berg personal email

n/a
About Robert Berg

Highly accomplished strategic CFO with experience in all areas of business and personnel management with demonstrated ability to create strategy and steer & grow the business with the aptitude to identify new markets and streamline business operations that increase efficiency and operating income. Trusted partner and investor known for creating strategic partnerships and high performing teams based on results, confidence and integrity.

Robert Berg's Current Company Details
Kindeva Drug Delivery

Kindeva Drug Delivery

View
CFO at Kindeva Drug Delivery
Robert Berg Work Experience Details
  • Kindeva Drug Delivery
    Cfo
    Kindeva Drug Delivery Dec 2022 - Present
    Woodbury, Minnesota, Us
    Merger of Altaris Private Equity owned companies Meridian and Kindeva (3M carve out)
  • Meridian Medical Technologies
    Cfo
    Meridian Medical Technologies Mar 2022 - Dec 2022
    St Louis, Missouri, Us
    Altaris Capital Partners-Private Equity owned carve out from Pfizer
  • Corerx, Inc.
    Cfo
    Corerx, Inc. Feb 2018 - Mar 2022
    Clearwater, Fl, Us
    Private Equity and Employee Owned with a successful exit of PE group-Signet Healthcare Partners 2021
  • Corerx, Inc.
    Corerx Cares Board Of Directors
    Corerx, Inc. Apr 2018 - Jan 2021
    Clearwater, Fl, Us
  • Hikma Pharmaceuticals
    Cfo
    Hikma Pharmaceuticals Mar 2016 - Jan 2018
    London, London, Gb
    Columbus Site Finance head and Leadership Team member for Manufacturing and Development Facility for Hikma Pharmaceuticals. Responsible for all financial integration and build back of shared service organization from Boehringer Ingelheim. Restructure site from Branded to Generic focusing on lean operations and efficiencies. Reorganized Finance Function to enable IFRS international accounting standard and worked with PWC to change the site financial reporting and controls from private to public.
  • Boehringer Ingelheim
    Cfo
    Boehringer Ingelheim Jan 2009 - Mar 2016
    Ingelheim Am Rhein, Rhineland-Palatinate, De
    Sale side finance lead on the Roxane Generics Business and Boehringer Ingelheim CDMO carve out-sold to Hikma/Westward Pharmaceuticals March 2016 for $2.1b. Columbus site Finance Head and Leadership Team member for Roxane labs Inc (Generic Business) and Boehringer Ingelheim Inc. -CDMO for Boehringer Ingelheim and External Customers. Board of Director and Treasurer for both companies. Responsible for Finance & Accounting, IT Systems & Strategic Sourcing and a leader to create and implement site strategy for the Generics Business and Global Manufacturing Operation. Identified new partners, products and technologies to grow the Generics pipeline along with business acquisition targets. Led the financial integration of an acquired Amgen Sterile Bio-pharmaceutical manufacturing facility in Fremont California and worked with management to set up metrics and balanced scorecard for the site. Leader in the implementation of a Lean/Flow conversion for the Columbus facility and worked closely with all International Corporate Functions on global teams to enable planning and execution of local and global strategies.
  • Boehringer Ingelheim
    Executive Director Finance-Usa
    Boehringer Ingelheim Dec 2007 - Dec 2008
    Ingelheim Am Rhein, Rhineland-Palatinate, De
    Led the US Corporate Planning function for Boehringer Ingelheim Pharmaceuticals with oversight on Budgets, Long Term Forecasts, financial consolidations, management reporting, Capital Planning & procedures. Consolidation of all US owned businesses including Chemical API Manufacturing, Branded Pharmaceutical's, Generic Divisions, Animal Health, Consumer Health Care and Biopharmaceuticals. Led the US Capital Invest Committee and supported all US company Board meetings. Work with all US Subsidiary Companies on strategy and long range financial planning.
  • Boehringer Ingelheim
    Executive Director Research & Development + Medical Controlling
    Boehringer Ingelheim 2005 - Nov 2007
    Ingelheim Am Rhein, Rhineland-Palatinate, De
    Led the Finance Controlling Organization in support of the Research & Development + Medical Groups. Senior leadership team member providing financial analysis & guidance to management setting strategy and goals for the groups. Worked on all external partnership agreements ensuring fulfillment of terms and conditions and led a six sigma/green belt program for R&D to reduce thru put time for drug development. Implemented Medical/Brand Marketing coordination tool and process to ensure messaging and targets aligned with strategy for the Medical Field Sales Teams- received the Presidents Award
  • Boehringer Ingelheim
    Director Medical Controlling
    Boehringer Ingelheim May 2003 - May 2005
    Ingelheim Am Rhein, Rhineland-Palatinate, De
    Led the Financial Controlling Organization in support of the Medical & Drug Regulatory Affairs Group. Responsible for all clinical trial payments and budgeting across eight therapeutic areas and Clinical Research Organizations (CRO). Member of the Medical Senior Leadership Team and also worked with Strategic Partners on alliance management, co drug development projects and negotiated with CRO/CDMO partners for clinical trial budgets, contracts and supplies. Team co lead to develop a global company wide clinical trial management (CTMS) tool for trial conduct, reporting and budgeting and also a member on global tax cost share project.
  • The Siemon Company
    Treasurer/Secretary -Siemon Company Board Of Directors
    The Siemon Company 2001 - 2003
    Watertown, Ct, Us
    Work directly with Family Owners on company strategy and direction, external financial advisors on portfolio family investments and all financial/administrative matters for the company.
  • The Siemon Company
    Head Of Corporate Finance
    The Siemon Company Jan 2000 - 2003
    Watertown, Ct, Us
    Responsible for Finance operations including US, Asia, Latin America and Europe. Lead the day to day operations at the company and set strategy for multiple business segments with long term planning and drove targeted business acquisitions/investment in technology to enable planned strategic growth. Worked with Leadership Team to enable business development in Europe, manufacturing expansion to Mexico, a lean manufacturing plant conversion for US facilities and to scale people, services, systems and equipment for success. Segmented the business divisions and worked to create long term strategies for growth. Led ERP implementation to Oracle solution. Work with Auditors E&Y directly on external US GAAP financial audit for all companies. Private family owned corporation.
  • Reckitt Benckiser
    Executive Director Of Finance-North America
    Reckitt Benckiser 1999 - Jan 2000
    Slough, Berkshire, Gb
    Responsible for all Accounting/Financial functions, Manufacturing Plant Finance, Sales Operations-Customer Service, Sales Forecasting & Analysis and Deduction Processing. Work directly with executive team on strategy and to manage product portfolio and brand profitability across all business units. Led Finance integration between Reckitt & Coleman + Benckiser and coordinated with Federal Trade Commission & acquiring companies sale of brands with anti trust concerns.
  • Benckiser Consumer Products (Johann A Benckiser /Jab Holdings-Private Equity Owned)
    Cfo-Usa/Corporate Controller North America/Controller Usa
    Benckiser Consumer Products (Johann A Benckiser /Jab Holdings-Private Equity Owned) 1992 - 1999
    P&L responsibility of consolidated $525m business. Leadership team member responsible for US strategy and execution, US GAAP financial audit, M&A opportunities, implementation and roll out of new ERP and CRM systems. Leader with the IPO for the US companies on the NYSE & AEX (Benckiser N.V.). Corporate Ex-Pat Assignment and Co Lead on a Global Profitability Project rollout to all countries sponsored by CEO (Bart Becht)-Head Office in Amsterdam Netherlands 1999.
  • Boehringer Ingelheim Pharmaceuticals
    Multiple Financial Roles
    Boehringer Ingelheim Pharmaceuticals Jun 1981 - Jul 1992
    Ingelheim Am Rhein, Rhineland-Palatinate, De
    Held progressively responsible positions in General Accounting, Plant Cost Accounting-cGMP facility, Research and Development Controlling and Financial Planning & Analysis. Project lead on a consulting assignment at Boehringer Ingelheim Animal Health Business in St Joseph Missouri to evaluate and improve company profitability-1991.
  • Boehringer Ingelheim Pharmaceuticals
    Board Member-Treasurer Boehringer Ingelheim Credit Union
    Boehringer Ingelheim Pharmaceuticals 1986 - 1992
    Ingelheim Am Rhein, Rhineland-Palatinate, De
    Elected Board Member and overall responsible for Audits, Investment Allocations, Financial Statements and Member Loan Approvals. Company sponsored credit union.

Robert Berg Skills

Auditing Team Building Sap Accounting Purchasing Generally Accepted Accounting Principles Cost Accounting Sales Financial Planning Forecasting Sales Operations Business Development Communication Regulatory Affairs Competitive Analysis Team Leadership Process Improvement Finance Erp Strategic Planning Strategy Business Planning Strategic Financial Planning Budgeting Marketing Cross Functional Team Leadership Manufacturing Internal Controls Managed Care Financial Analysis Project Planning Business Process Improvement Sarbanes Oxley Act Budgets Business Strategy Management Financial Reporting Lean Six Sigma Strategic Alliances Accounts Payable Erp Implementations Mergers And Acquisitions Crm Analysis

Robert Berg Education Details

  • Insead
    Insead
    -New Market Development/Business Growth Strategy
  • Miami University
    Miami University
    Economics
  • University Of Michigan - Stephen M. Ross School Of Business
    University Of Michigan - Stephen M. Ross School Of Business
    Executive Education- Leadership And Change
  • Iassc Certified Lean Six Sigma Green Belt
    Iassc Certified Lean Six Sigma Green Belt
  • University Of New Haven
    University Of New Haven
    Business Administration & Finance
  • Assumption University
    Assumption University
    Economics & Business Studies

Frequently Asked Questions about Robert Berg

What company does Robert Berg work for?

Robert Berg works for Kindeva Drug Delivery

What is Robert Berg's role at the current company?

Robert Berg's current role is CFO at Kindeva Drug Delivery.

What is Robert Berg's email address?

Robert Berg's email address is ro****@****add.com

What is Robert Berg's direct phone number?

Robert Berg's direct phone number is +130567*****

What schools did Robert Berg attend?

Robert Berg attended Insead, Miami University, University Of Michigan - Stephen M. Ross School Of Business, Iassc Certified Lean Six Sigma Green Belt, University Of New Haven, Assumption University.

What skills is Robert Berg known for?

Robert Berg has skills like Auditing, Team Building, Sap, Accounting, Purchasing, Generally Accepted Accounting Principles, Cost Accounting, Sales, Financial Planning, Forecasting, Sales Operations, Business Development.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.